Bhagiradha Chemicals & Industries Limited — Important, 21-02-2025: Updates

The Company has received listing approval from BSE Limited for 52,34,100 equity shares of Re. 1 each, which were allotted following the conversion of warrants on a preferential basis. The allotted shares include a premium of Rs. 132.20. This move enhances the company's share capital base, potentially increasing liquidity and market visibility.

Successful listing and subsequent trading of these shares on the exchange could positively impact shareholder value, offering improved investment appeal. Attention will be required regarding compliance with listing regulations and timely submission of necessary approvals for trading to commence, which presents a potential risk of non-compliance.

In summary, the company's recent developments may signal a strong position in the market, warranting close observation for investors looking for growth opportunities.